Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Perampanel flap

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Perampanel

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,591Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MSN Lab`s Generics Perampanel Receive Tentative Approval in US
    MSN Lab`s Generics Perampanel Receive Tentative Approval in US

    08 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218178

    FDA
    08 Jan 2025
    Share Share
    MSN Lab`s Generics Perampanel Receives Tentative Approval in US
    MSN Lab`s Generics Perampanel Receives Tentative Approval in US

    16 Dec 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218152

    FDA
    16 Dec 2024
    Share Share
    Teva Pharms's Generic Perampanel Receives Tentative Approval in US
    Teva Pharms's Generic Perampanel Receives Tentative Approval in US

    04 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209801

    FDA
    04 Jun 2024
    Share Share
    Eisai's antiepileptic drug Fycompa injection formulation launches in Japan
    Eisai's antiepileptic drug Fycompa injection formulation launches in Japan

    18 Apr 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24098/eisais-antiepileptic-drug-fycompa-injection-formulation-launches-in-japan.html

    BIOSPECTRUM ASIA
    18 Apr 2024
    Share Share
    Ligand Partner Eisai Receives Approval for Injection Formulation of Fycompa
    Ligand Partner Eisai Receives Approval for Injection Formulation of Fycompa

    22 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240222424618/en

    BUSINESSWIRE
    22 Feb 2024
    Share Share
    Catalyst Announces Multiple Abstracts on FYCOMPA from Eisai to be Presented
    Catalyst Announces Multiple Abstracts on FYCOMPA from Eisai to be Presented

    14 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/14/2724366/13009/en/Catalyst-Pharmaceuticals-Announces-Multiple-Abstracts-on-FYCOMPA-Perampanel-from-Eisai-Co-Ltd-to-be-Presented-at-the-35th-International-Epilepsy-Congress.html

    GLOBENEWSWIRE
    14 Aug 2023
    Share Share